abstract |
The present invention provides a genetically-modified, non-human mammalnhaving an altered body fat composition, wherein said mammal comprises annexogenous mutant p85 P13-K gene, wherein the expression of said gene is drivennby an insulin responsive cell specific promoter. The present invention also relatesnto transgenic cell lines containing the same mutant gene, as well as methods usingnboth animals and/or cells. |